Clinical trial
Efficacy & Safety of the Oral Neurokinin-1 Antagonist, Aprepitant, in Combo With…
NCT00314743 · Washington University School of Medicine, Other · Completed
Key facts
| NCT number | NCT00314743 |
|---|---|
| Title | Efficacy & Safety of the Oral Neurokinin-1 Antagonist, Aprepitant, in Combo With Ondansetron & Dexamethasone in Patients Undergoing Auto Peripheral Blood Stem Cell Transplantation |
| Official title | A Study Evaluating the Efficacy and Safety of the Oral Neurokinin-1 Antagonist, Aprepitant, in Combination With Ondansetron and Dexamethasone in Patients Undergoing Autologous Peripheral Blood Stem Cell Transplantation |
| Lead sponsor | Washington University School of Medicine, Other |
| Status | Completed |
| Phase | Early Phase 1 |
| Study type | Interventional |
| Conditions | Nausea, Vomiting |
| Intervention type | Drug |
| Interventions | Ondansetron, Dexamethasone, Aprepitant |
| Enrollment | 48 |
| Start date | Oct 1, 2005 |
| Primary completion | Dec 1, 2008 |
| Completion | Dec 1, 2008 |
| First posted | Apr 14, 2006 |
| Last update posted | May 24, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: